MiroBio
is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of auto-immune diseases... Read moreMiroBio
is an England-based biotechnology company that develops and commercializes novel therapeutics for the treatment of auto-immune diseases... Read more
News
Sep 21, 2022
PMLiVE
MiroBio: Gilead completes acquisition of MiroBio in $405m cash deal
Aug 11, 2022
Global Legal Chronicle
MiroBio: Gilead Sciences' $405 Million Acquisition of MiroBio
Aug 09, 2022
Business and Innovation Magazine
MiroBio: Gilead Sciences to acquire Oxford Uni biotech spinout Microbio for $450 million
Aug 05, 2022
PharmaLive
MiroBio: Gilead Bets $405M on MiroBio's Checkpoint Agonists for Autoimmune Disease
Aug 04, 2022
Benzinga
MiroBio: Gilead Sciences Bets $400M On Inflammatory Diseases Focused UK Based Firm
Jul 05, 2022
Global Legal Chronicle
MiroBio: MiroBio's $97 Million Series B Financing
Jun 30, 2022
Business and Innovation Magazine
MiroBio: Oxford-based Mirobio raises 80M to help treat autoimmune diseases
Jun 29, 2022
LondonLovesBusiness
MiroBio: MiroBio raises $97m Series B financing to develop checkpoint agonists for treatment of autoimmune diseases
Jun 29, 2022
Owler
MiroBio Limited: MiroBio's employee count changed from 16 in Sep 2021 to 29 in Jun 2022
Mar 08, 2022
FirstWord Pharma
MiroBio: MiroBio Expands Executive Leadership Team
